CCL2 and neoplasm: Using C.M. collected from MSCs treated with siRNA targeting either IL1RN or CCL2, we also observed the inhibition of proliferation; however, the mechanism was not likely due to the IL-28 related pathway, since the tumor cells were not sensitive to exogenous IL-28 at high concentrations (Figure 3).